Corfluvec
/ Smorodintsev Research Institute of Influenza
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
June 15, 2023
Evaluation of Corfluvec Vaccine for the Prevention of COVID-19 in Healthy Volunteers
(clinicaltrials.gov)
- P1/2 | N=200 | Completed | Sponsor: Tatyana Zubkova | Active, not recruiting ➔ Completed
Trial completion • Infectious Disease • Novel Coronavirus Disease
January 25, 2023
Evaluation of Corfluvec Vaccine for the Prevention of COVID-19 in Healthy Volunteers
(clinicaltrials.gov)
- P1/2 | N=200 | Active, not recruiting | Sponsor: Tatyana Zubkova
New P1/2 trial • Infectious Disease • Novel Coronavirus Disease
1 to 2
Of
2
Go to page
1